6825-71-4

Basic information

• Product Name: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate
• Synonyms: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate;3,5-Diamino-4-ethoxycarbonylpyrazole;Ethyl 3,5-diamino-4-pyrazolecarboxylate;1H-Pyrazole-4-carboxylic acid, 3,5-diamino-, ethyl ester;3,5-Diamino-1H-pyrazole-4-carboxylic acid ethyl ester;EOS-61556
• CAS NO: 6825-71-4
• Molecular Formula: C₆H₁₀N₄O₂
• Molecular Weight: 170
• Mol File: 6825-71-4.mol
• Article Data: 11

Chemical Properties

• Melting Point: 189-190℃
• Boiling Point: 419.4±40.0 °C(Predicted)
• Appearance: /
• Density: 1.418±0.06 g/cm3(Predicted)
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 14.26±0.50(Predicted)
• CAS DataBase Reference: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(6825-71-4)
• EPA Substance Registry System: ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate(6825-71-4)

Safety Data

• Hazardous Substances Data: 6825-71-4(Hazardous Substances Data)

Usage

Uses

Ethyl 3,5-diaMino-1H-pyrazole-4-carboxylate belongs to carboxylic acid ester derivatives, which can be used as pharmaceutical intermediates and used in medical experimental research.

Upstream product

• 121020-70-0 2-(cyanoethoxycarbonylmethylene)-1,3-dioxolane 
• 22071-00-7 1-Amino-1-trichlormethyl-2-carbethoxy-2-cyano-ethylen 
• 49765-05-1 (Z) 3-amino-4,4,4-trichloro-2-cyano-2-butenoic acid ethyl ester 
• 105-56-6 ethyl 2-cyanoacetate 

Downstream Products

• 82819-95-2 2-amino-3-ethoxycarbonyl-5-hydroxy-7-phenylpyrazolo<1,5-a>pyrimidine 
• 74440-35-0 3,5-Diamino-1H-pyrazole-4-carboxylic acid hydrazide 
• 82819-89-4 3-phenylpropiolamido-4-ethoxycarbonyl-5-aminopyrazole 

Relevant articles and documents

Alkyne derivative, preparation method and application thereof

The invention relates to an alkyne derivative and a preparation method thereof and application of the alkyne derivative in medicine, specifically to an alkyne derivative represented by general formula(I), a preparation method and a pharmaceutically accept

Larotinib derivative and preparation method and application thereof

The invention relates to a larotinib derivative and a preparation method and application thereof, and provides a novel larotinib derivative with anti-tumor activity. The novel larotinib derivative isbeneficial to improving the anti-tumor activity of the l

MACROCYCLIC COMPOUNDS AND USES THEREOF

The present disclosure relates to certain macrocyclic compounds that inhibit SRC and MET, and/or CSF1R, pharmaceutical compositions containing such compounds, and methods of using such compounds to treat cancer.